awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30659342-F120606B-C6AE-4957-AFAB-9073FAF0DE9C
Q30659342-F120606B-C6AE-4957-AFAB-9073FAF0DE9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30659342-F120606B-C6AE-4957-AFAB-9073FAF0DE9C
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy
P2860
Q30659342-F120606B-C6AE-4957-AFAB-9073FAF0DE9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30659342-F120606B-C6AE-4957-AFAB-9073FAF0DE9C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52880c5b75504e4df12e6e8ffcf4e3b64d83796d
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.